Discoid lupus erythematosus rash
Lupus pictures
April 14th, 2010The side effects of corticosteroids on lupus treatment
April 14th, 2010
The benefits of corticosteroids in lupus treatment can be measured in terms of increased life expectancy. In 1955, the survival rate at five years for lupus patients was only 50%. By 1995, the survival rate at 20 years had already reached 80%. In fact, many women stay healthy to keep their works for decades after diagnosis with lupus disease.
Even though corticosteroids have a benefit in lupus treatment, the risks of corticosteroids are Read the rest of this entry »
Lupus and its effect to the eyes
April 14th, 2010
Monitoring eye health in lupus patients is important. First, lupus ocular complications are potentially blinding and second, eye symptoms are an indication of less obvious disease activity, such as kidney damage, that tends to occur in cycles of exacerbation and remission. Medications used to treat lupus disease can have widely side effects involving the eye, but the disease itself can cause much more damage to the eye system. Thus Read the rest of this entry »
The 9th international lupus congress
April 10th, 2010
The next International Lupus Congress will be held June 24-27, 2010 in Vancouver, Canada. The Congress is a triennial meeting in which physicians, researchers and patients come together to share the latest research and developments in lupus disease.
The congress will include 3-day professional and patient education symposia featuring presentations from more than 60 of the world’s top lupus research and outreach experts, and a Read the rest of this entry »
IgM anti-dsDNA antibodies for the treatment and prevention of lupus nephritis
April 7th, 2010
This research identifies an antibody that induces a protective effect in vivo in a lab rat model of lupus nephritis. The lupus nephritis-model mice that were treated with this antibody experienced a dramatic increase in survival, demonstrated a reduced immune complex formation deposition in the kidneys, and displayed low levels of proteinuria as compared with untreated mice. The antibody is an autospecific anti-dsDNA IgM. Read the rest of this entry »
Lupus and pregnancy
April 6th, 2010
Pregnancy risk is routinely dynamic upon the standing of the woman with lupus disease in many cases. Women that have the amiable form of the mildew have been in discount as good as have been during the low risk. The risk of premature birth customarily increases with women in the tall risk operation that would be women with active lupus myocarditis.
About twenty percent of the women in the high-risk difficulty go by their conceiving physically Read the rest of this entry »
New therapies for lupus may be developed after HVCN1 protein discovered
March 15th, 2010
Medical Research Council (MRC) researchers at the University of Leicester have discovered a protein called HVCN1. This protein regulates antibody production through modulation of intracellular oxidation. In the absence of this protein, the immune response is dull. These findings are very novel and significantly contribute to our understanding of how the organism mounts an immune response. Read the rest of this entry »
